The protective effects of systemic IL-1Ra in different models of brain injury are widely recognised (Maysami et al., 2016), therefore further understanding of the cell-specific actions of IL-1 will need to be better understood to achieve a maximal potential for the therapeutic blockade of IL-1 actions in brain diseases. This evidence concerns the gene IL1A and brain disorder.